Client Alerts & Insights

SEC Enhanced Proxy Disclosure Rules

December 1, 2009

On December 16, 2009, the Securities and Exchange Commission voted 4-1 to approve amendments to its rules that will require expanded disclosure requirements for U.S. public companies, effective February 28, 2010, including:

  • Providing narrative disclosure of the Company’s compensation policies and practices as they may relate to the Company’s risk management;
  • Revising reporting requirements for stock and option awards in the summary compensation table;
  • Requiring enhanced disclosure of the background and qualifications of directors and nominees, including greater litigation disclosure, and the role of diversity in the nomination process;
  • Requiring new disclosure about a Company’s Board leadership structure and the Board’s role in risk oversight;
  • Requiring new disclosure regarding a Company’s use of compensation consultants, potential conflicts of interest and the fees paid to such consultants; and
  • Reporting of voting results on Form 8-K within four days of the annual meeting, rather than waiting for the next Form 10-Q or 10-K.

For additional information, please contact:

Megan L. Mehalko at (216) 363-4487 or mmehalko@beneschlaw.com


Latest News

Client Alerts & Insights 8.11.26

Third Circuit Decision Reshapes Creditor Standing in Successor Liability Disputes

The Third Circuit recently held that when determining whether a successor liability claim belongs to a bankruptcy estate, the key question is whether the claim seeks to remedy harm suffered by all creditors collectively or a unique injury suffered by a specific creditor. The fact that creditors may be permitted to bring the claim outside of bankruptcy is not, by itself, determinative.

Client Alerts & Insights 7.28.26

CMS Proposes Sweeping Restrictions on Remote Patient Monitoring: The Outsourcing Ban, Reimbursement Revaluation and Potential Code Consolidation in the CY 2027 Physician Fee Schedule Proposed Rule

CMS’s CY 2027 Proposed Rule would significantly restrict Medicare reimbursement for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), including banning outsourced clinical staffing, adding new patient-relationship and initiating-visit requirements, reducing certain reimbursement rates, and exploring consolidation of existing billing codes.